Velpharma ApS — Credit Rating and Financial Key Figures
CVR number: 43655701
Frederikssundsvej 68 B, 2400 København NV
Income statement (kDKK)
2023 | 2024 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | -11.30 | -41.60 |
EBIT | -11.30 | -41.60 |
Pre-tax profit | -11.30 | -41.60 |
Net earnings | -11.30 | -41.60 |
Assets (kDKK)
2023 | 2024 | |
---|---|---|
Intangible assets total | ||
Tangible assets total | ||
Investments total | ||
Long term receivables total | ||
Inventories total | ||
Current other receivables | 0.76 | 10.19 |
Short term receivables total | 0.76 | 10.19 |
Cash and bank deposits | 83.81 | 32.78 |
Cash and cash equivalents | 83.81 | 32.78 |
Balance sheet total (assets) | 84.57 | 42.97 |
Equity and liabilities (kDKK)
2023 | 2024 | |
---|---|---|
Share capital | 40.00 | 40.00 |
Retained earnings | -11.30 | |
Profit of the financial year | -11.30 | -41.60 |
Shareholders equity total | 28.70 | -12.90 |
Non-current liabilities total | ||
Current owed to participating | 1.48 | 1.48 |
Current owed to group member | 54.39 | 54.39 |
Current liabilities total | 55.87 | 55.87 |
Balance sheet total (liabilities) | 84.57 | 42.97 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.